In this edition of the biotech bi-weekly, get the latest industry news – from the expansion of single-cell RNA sequencing capabilities in Cambridge, UK, and next-generation enzymatic DNA synthesis technology across India, to a free trial program allowing customers to test an advanced nuclease and the program announcement for The Antibody Series 2026 (Évora, Portugal; 16–18 September). Products Free trial program allows customers to test an advanced nuclease Sino Biological (Beijing, China), a recombinant technology company, has announced the launch of SuperNuclease® Pro. This advanced nuclease is engineered to deliver enhanced nucleic acid removal performance for demanding bioprocessing and molecular...To view this content, please register now for access Join our member community for FREE to access a collection of journal and online-only features, including: Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articlesand insights into top The latest news and journal updates delivered straight to your inbox when you want itand when you want it Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinionsfor the latest Priority registration to webinars, panel discussions and eventsAccess to competitions and journal publication discounts, including 10% off open access fees when you sign up today! Register Login